Sabeluzole Enhances Spontaneous EEG Activity and SSEP, and Accelerates Their Posthypoxic Recovery in Rat

Conference paper


The therapeutic amelioration of ischemia or hypoxia-induced neuronal dysfunction and disability is one of the most important tasks in clinical neurology. A novel drug, Sabeluzole (R 58735), has been shown to improve the posthypoxic survival chances in rats [10], prevent neuronal damage induced by hypoxic insult in rats [9], and antagonize posthypoxic memory deficits in guinea pigs [4]. Apart from these antihypoxic effects, the compound has also been shown to improve learning capacity and memory functions of rats [3], guinea pigs [6], and humans [5]. However, the mechanisms underlying these beneficial effects of Sabeluzole on neuronal functions are not understood. In the present study, we investigated the effects of Sabeluzole on the somatosensory evoked cortical potentials (SSEP) and the spontaneous EEG activities in order to obtain more information about the mode of action of Sabeluzole.


Mean Arterial Blood Pressure Extracellular Potassium Hypoxic Insult Negative Spike Drug Development Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Allison T, Hume AL (1981) A comparison analysis of short-latency somatosensory evoked potentials in man, monkey, cat, and rat. Exp Neurol 72:592–611PubMedCrossRefGoogle Scholar
  2. 2.
    Ashton D, Fransen JF, Wauquier A (1984) Pharmacological profile of a new antihypoxic and anticonvulsant drug: R56164. Part 2. R56164 produced alterations in bicuculline seizure threshold; a comparison with diphenylhydantoin and carbamazepine. Preclinical Research Report R56164/2, Janssen Pharmaceutica, Beerse, BelgiumGoogle Scholar
  3. 3.
    Clincke G, Sahgal A (1986) R58735, a novel antihypoxic drug improves memory in rats. Drug Development Research 8:381–385CrossRefGoogle Scholar
  4. 4.
    Clincke G, Wauquier A (1984) Pharmacological profile of a new antihypoxic and anticonvulsant drug: R56164. Part 5. Antagonism of hypoxia-induced memory deficits and positive effects on learning (acquisition) with R58735 [base of R56164 (HCl)]. Preclinical Research Report R58735/2, Janssen Pharmaceutica, Beerse, BelgiumGoogle Scholar
  5. 5.
    Clincke GHC, Tritsmans L, Idzikowski C, Amery WK, Janssen PAJ (1988) The effect of R58735 (sabeluzole) on memory functions in healthy elderly volunteers. Psychopharmacology 94:52–57PubMedCrossRefGoogle Scholar
  6. 6.
    Clincke GHC, Van Loon J, Wauquier A (1987) The effects of sabeluzole on working memory in a delayed comparison task in the guinea-pig. Preclinical Research Report R58735/16, Janssen Pharmaceutica, Beerse, Belgium.Google Scholar
  7. 7.
    De Ryck M, Duytschaever H, Clincke GHC, Wauquier A, Janssen PAJ (1989) Anticholinergics reinstate sensorimotor deficits in rats with neocortical damage: protective effects of sabeluzole. Annual Meeting of the Society for Neuroscience, Phoenix, Arizona, October 29-November 3, 1989Google Scholar
  8. 8.
    Leysen JE, Verwimp M, Gommeren W (1986) In vitro receptor binding and neurotransmitter uptake inhibition profile of the anti-hypoxic agent R58735. Preclinical Research Report R58735/14, Janssen Pharmaceutica, Beerse, BelgiumGoogle Scholar
  9. 9.
    Van Reempts J, Van Deuren B, Haseldoncks M, Van de Ven M, Borgers M (1986) Structural cell damage and regional blood flow in the hypoxic brain: effects of treatment with R58735, a novel antihypoxic drug. In: Kriegelstein J (ed) Proceedings of the international symposium on pharmacology of cerebral ischemia. Elsevier, Amstendam New York Oxford, pp 385–390Google Scholar
  10. 10.
    Wauquier A, Clincke G, Ashton D, De Ryck M, Fransen J, Van Clemen G (1986) R58735: a new antihypoxic drug with anticonvulsant properties and possible effects on cognitive functions. Drug Development Research 8:373–380CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Y. Xie
    • 1
  1. 1.Janssen Research FoundationNeuss 21Germany

Personalised recommendations